Alzheimer’s Disease Nasal Vaccine To Be Tested At Brigham And Women’s Hospital
Brigham and Women’s Hospital is going to test a nasal vaccine for Alzheimer’s Disease.
The hospital announced the launch of a clinical trial Tuesday to test the safety and efficacy of the medicine, which has been researched for nearly 20 years.
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.